Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. prepares novel fatty-acid amide hydrolase 1 inhibitors

Nov. 14, 2011

New PHD2 inhibitors for anemia patented

Nov. 14, 2011

Canadian organization prepares novel protein kinase inhibitors

Nov. 11, 2011

New cytochrome P450 19A1 inhibitors patented in U.S.

Nov. 11, 2011

Boehringer Ingelheim presents novel PDK1 inhibitors

Nov. 11, 2011

Novel glutaminyl-peptide cyclotransferase inhibitors synthesized by Probiodrug

Nov. 11, 2011

Merck & Co. discloses new protein kinase inhibitors

Nov. 11, 2011

MIT discloses novel targeted siRNA nanocomplexes for ovarian cancer

Nov. 10, 2011

Merck & Co. claims new products for anemia

Nov. 10, 2011

Peking University synthesizes novel agents to treat cancer

Nov. 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...